1. Home
  2. AGMB vs CXII Comparison

AGMB vs CXII Comparison

Compare AGMB & CXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$5.54

Market Cap

576.2M

Sector

Health Care

ML Signal

N/A

CXII

Churchill Capital Corp XII Class A Ordinary Shares

N/A

Current Price

$10.48

Market Cap

597.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AGMB
CXII
Founded
2017
2026
Country
Belgium
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
576.2M
597.4M
IPO Year
2024
2026

Fundamental Metrics

Financial Performance
Metric
AGMB
CXII
Price
$5.54
$10.48
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $37.67
N/A
AVG Volume (30 Days)
★ 297.3K
24.9K
Earning Date
12-01-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$10.05
52 Week High
$17.82
$10.99

Technical Indicators

Market Signals
Indicator
AGMB
CXII
Relative Strength Index (RSI) 23.66 34.59
Support Level N/A N/A
Resistance Level $9.55 $10.47
Average True Range (ATR) 0.69 0.03
MACD -0.04 -0.00
Stochastic Oscillator 5.17 0.00

Price Performance

Historical Comparison
AGMB
CXII

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

About CXII Churchill Capital Corp XII Class A Ordinary Shares

Churchill Capital Corp XII is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: